DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Lenz HJ et al.
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
J Clin Oncol 2006;
24 (30) 4914-4921
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.